Professional
Added to YB: 2026-09-16
Pitch date: 2026-07-14
MCK [bullish]
McKesson Corporation
+14%
current return
Author Info
JAG actively manages focused equity and fixed income portfolios for institutions, intermediaries, and individuals. Sign up for the newsletter.
Company Info
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions.
Market Cap
$102.8B
Pitch Price
$799.10
Price Target
N/A
Dividend
0.43%
EV/EBITDA
14.73
P/E
23.52
EV/Sales
0.27
Sector
Health Care Providers and Services
Category
growth
JAG Large Cap Growth New Position: McKesson Corporation
MCK: McKesson is one of three dominant U.S. drug distributors and has undergone a meaningful transformation by divesting non-core assets and redeploying capital into higher-growth markets, including oncology and multi-specialty practices. The investment case rests on this shift toward faster-growing healthcare segments, though the brief overview provides no valuation, financial evidence, catalyst timeline or material risk assessment.
Read full article (1 min)